カテゴリー： GlobalInfoResearch, 世界

胃がんの検査・治療・予防の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）

【英語タイトル】Global Gastric Cancer Testing, Treatment and Prevention Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが出版した調査資料（GIR9102024）・商品コード：GIR9102024
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2019年9月16日（※2024年版があります。お問い合わせください）
・ページ数：123
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥515,040見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）USD5,220 ⇒換算￥772,560見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,030,080見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本調査レポートは、胃がんの検査・治療・予防の世界市場について調べ、まとめました。種類別セグメントは、検査、治療、予防等、用途別セグメントは、病院、診療所、その他等に区分しました。胃がんの検査・治療・予防の世界市場概観、企業動向、企業別胃がんの検査・治療・予防シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・胃がんの検査・治療・予防の市場概観
・胃がんの検査・治療・予防の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・胃がんの検査・治療・予防の企業別販売動向、市場シェア、市場集中度、競争動向
・胃がんの検査・治療・予防の世界市場規模
・胃がんの検査・治療・予防の北米市場分析（アメリカ、カナダ、メキシコ等）
・胃がんの検査・治療・予防のアメリカ市場規模推移
・胃がんの検査・治療・予防のカナダ市場規模推移
・胃がんの検査・治療・予防のメキシコ市場規模推移
・胃がんの検査・治療・予防のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・胃がんの検査・治療・予防のドイツ市場規模推移
・胃がんの検査・治療・予防のイギリス市場規模推移
・胃がんの検査・治療・予防のロシア市場規模推移
・胃がんの検査・治療・予防のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・胃がんの検査・治療・予防の日本市場規模推移
・胃がんの検査・治療・予防の中国市場規模推移
・胃がんの検査・治療・予防の韓国市場規模推移
・胃がんの検査・治療・予防のインド市場規模推移
・胃がんの検査・治療・予防の東南アジア市場規模推移
・胃がんの検査・治療・予防の南米市場分析（ブラジル、アルゼンチン等）
・胃がんの検査・治療・予防の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・胃がんの検査・治療・予防の種類別分析/販売量、売上、市場シェア（検査、治療、予防）
・胃がんの検査・治療・予防の用途別分析/市場規模（病院、診療所、その他）
・胃がんの検査・治療・予防の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・胃がんの検査・治療・予防の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Stomach cancer begins when cancer cells form in the inner lining of your stomach. These cells can grow into a tumor. Also called gastric cancer, the disease usually grows slowly over many years. There may be no symptoms of stomach cancer early on. Later, symptoms include feeling bloated after eating, feeling full after eating small amounts of food, nausea, heartburn, or indigestion.

Scope of the Report:
The global Gastric Cancer Testing, Treatment and Prevention market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Gastric Cancer Testing, Treatment and Prevention.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Gastric Cancer Testing, Treatment and Prevention market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gastric Cancer Testing, Treatment and Prevention market by product type and applications/end industries.

Market Segment by Companies, this report covers
Biogen Idec
Bristol Myers Squibb
Eli Lilly And Company
Glaxosmithkline Genentech, Inc
Hoffmann-La Roche Inc.
Immunogen Merck & Company
Novartis
Pacific Edge Diagnostics Nz
Pfizer
Roche/Genentech Oncolytics
Zova Biotherapeutics Inc.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Test
Treatment
Prevention

Market Segment by Applications, can be divided into
Hospitals
Clinics
Other

【レポートの目次】

Table of Contents

1 Gastric Cancer Testing, Treatment and Prevention Market Overview
1.1 Product Overview and Scope of Gastric Cancer Testing, Treatment and Prevention
1.2 Classification of Gastric Cancer Testing, Treatment and Prevention by Types
1.2.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue Comparison by Types (2019-2024)
1.2.2 Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Types in 2018
1.2.3 Test
1.2.4 Treatment
1.2.5 Prevention
1.3 Global Gastric Cancer Testing, Treatment and Prevention Market by Application
1.3.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Gastric Cancer Testing, Treatment and Prevention Market by Regions
1.4.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Gastric Cancer Testing, Treatment and Prevention Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Gastric Cancer Testing, Treatment and Prevention Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gastric Cancer Testing, Treatment and Prevention Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Gastric Cancer Testing, Treatment and Prevention Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gastric Cancer Testing, Treatment and Prevention Status and Prospect (2014-2024)
1.5 Global Market Size of Gastric Cancer Testing, Treatment and Prevention (2014-2024)
2 Manufacturers Profiles
2.1 Biogen Idec
2.1.1 Business Overview
2.1.2 Gastric Cancer Testing, Treatment and Prevention Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Biogen Idec Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bristol Myers Squibb
2.2.1 Business Overview
2.2.2 Gastric Cancer Testing, Treatment and Prevention Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
2.3 Eli Lilly And Company
2.3.1 Business Overview
2.3.2 Gastric Cancer Testing, Treatment and Prevention Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
2.4 Glaxosmithkline Genentech, Inc
2.4.1 Business Overview
2.4.2 Gastric Cancer Testing, Treatment and Prevention Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
2.5 Hoffmann-La Roche Inc.
2.5.1 Business Overview
2.5.2 Gastric Cancer Testing, Treatment and Prevention Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
2.6 Immunogen Merck & Company
2.6.1 Business Overview
2.6.2 Gastric Cancer Testing, Treatment and Prevention Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
2.7 Novartis
2.7.1 Business Overview
2.7.2 Gastric Cancer Testing, Treatment and Prevention Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Novartis Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
2.8 Pacific Edge Diagnostics Nz
2.8.1 Business Overview
2.8.2 Gastric Cancer Testing, Treatment and Prevention Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Gastric Cancer Testing, Treatment and Prevention Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
2.10 Roche/Genentech Oncolytics
2.10.1 Business Overview
2.10.2 Gastric Cancer Testing, Treatment and Prevention Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
2.11 Zova Biotherapeutics Inc.
2.11.1 Business Overview
2.11.2 Gastric Cancer Testing, Treatment and Prevention Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
3 Global Gastric Cancer Testing, Treatment and Prevention Market Competition, by Players
3.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Gastric Cancer Testing, Treatment and Prevention Players Market Share
3.2.2 Top 10 Gastric Cancer Testing, Treatment and Prevention Players Market Share
3.3 Market Competition Trend
4 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Regions
4.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue and Market Share by Regions
4.2 North America Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
4.3 Europe Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
4.5 South America Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
5 North America Gastric Cancer Testing, Treatment and Prevention Revenue by Countries
5.1 North America Gastric Cancer Testing, Treatment and Prevention Revenue by Countries (2014-2019)
5.2 USA Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
5.3 Canada Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
5.4 Mexico Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
6 Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Countries
6.1 Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Countries (2014-2019)
6.2 Germany Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
6.3 UK Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
6.4 France Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
6.5 Russia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
6.6 Italy Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Countries
7.1 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Countries (2014-2019)
7.2 China Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
7.3 Japan Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
7.4 Korea Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
7.5 India Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
8 South America Gastric Cancer Testing, Treatment and Prevention Revenue by Countries
8.1 South America Gastric Cancer Testing, Treatment and Prevention Revenue by Countries (2014-2019)
8.2 Brazil Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
8.3 Argentina Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
8.4 Colombia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Gastric Cancer Testing, Treatment and Prevention by Countries
9.1 Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Countries (2014-2019)
9.2 Saudi Arabia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
9.3 UAE Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
9.4 Egypt Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
9.5 Nigeria Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
9.6 South Africa Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
10 Global Gastric Cancer Testing, Treatment and Prevention Market Segment by Type
10.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue and Market Share by Type (2014-2019)
10.2 Global Gastric Cancer Testing, Treatment and Prevention Market Forecast by Type (2019-2024)
10.3 Test Revenue Growth Rate (2014-2024)
10.4 Treatment Revenue Growth Rate (2014-2024)
10.5 Prevention Revenue Growth Rate (2014-2024)
11 Global Gastric Cancer Testing, Treatment and Prevention Market Segment by Application
11.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Application (2014-2019)
11.2 Gastric Cancer Testing, Treatment and Prevention Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Clinics Revenue Growth (2014-2019)
11.5 Other Revenue Growth (2014-2019)
12 Global Gastric Cancer Testing, Treatment and Prevention Market Size Forecast (2019-2024)
12.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size Forecast (2019-2024)
12.2 Global Gastric Cancer Testing, Treatment and Prevention Market Forecast by Regions (2019-2024)
12.3 North America Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2019-2024)
12.4 Europe Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2019-2024)
12.6 South America Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Gastric Cancer Testing, Treatment and Prevention Picture
Table Product Specifications of Gastric Cancer Testing, Treatment and Prevention
Table Global Gastric Cancer Testing, Treatment and Prevention and Revenue (Million USD) Market Split by Product Type
Figure Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Types in 2018
Figure Test Picture
Figure Treatment Picture
Figure Prevention Picture
Table Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) by Application (2014-2024)
Figure Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Clinics Picture
Figure Other Picture
Table Global Market Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate (2014-2024)
Table Biogen Idec Basic Information, Manufacturing Base and Competitors
Table Biogen Idec Gastric Cancer Testing, Treatment and Prevention Type and Applications
Table Biogen Idec Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Type and Applications
Table Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly And Company Basic Information, Manufacturing Base and Competitors
Table Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Type and Applications
Table Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
Table Glaxosmithkline Genentech, Inc Basic Information, Manufacturing Base and Competitors
Table Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Type and Applications
Table Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
Table Hoffmann-La Roche Inc. Basic Information, Manufacturing Base and Competitors
Table Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Type and Applications
Table Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
Table Immunogen Merck & Company Basic Information, Manufacturing Base and Competitors
Table Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Type and Applications
Table Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Gastric Cancer Testing, Treatment and Prevention Type and Applications
Table Novartis Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
Table Pacific Edge Diagnostics Nz Basic Information, Manufacturing Base and Competitors
Table Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Type and Applications
Table Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Gastric Cancer Testing, Treatment and Prevention Type and Applications
Table Pfizer Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
Table Roche/Genentech Oncolytics Basic Information, Manufacturing Base and Competitors
Table Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Type and Applications
Table Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
Table Zova Biotherapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Type and Applications
Table Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2017-2018)
Table Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) by Players (2014-2019)
Table Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Players (2014-2019)
Figure Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Players in 2017
Figure Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Players in 2018
Figure Global Top 5 Players Gastric Cancer Testing, Treatment and Prevention Revenue Market Share in 2018
Figure Global Top 10 Players Gastric Cancer Testing, Treatment and Prevention Revenue Market Share in 2018
Figure Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) by Regions (2014-2019)
Table Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Regions (2014-2019)
Figure Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Regions (2014-2019)
Figure Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Regions in 2018
Figure North America Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure Europe Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure South America Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Table North America Gastric Cancer Testing, Treatment and Prevention Revenue by Countries (2014-2019)
Table North America Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2014-2019)
Figure North America Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2014-2019)
Figure North America Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries in 2018
Figure USA Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure Canada Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure Mexico Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Table Europe Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) by Countries (2014-2019)
Figure Europe Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2014-2019)
Figure Europe Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries in 2018
Figure Germany Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure UK Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure France Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure Russia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure Italy Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries in 2018
Figure China Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure Japan Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure Korea Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure India Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Table South America Gastric Cancer Testing, Treatment and Prevention Revenue by Countries (2014-2019)
Table South America Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2014-2019)
Figure South America Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2014-2019)
Figure South America Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries in 2018
Figure Brazil Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure Argentina Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure Colombia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries in 2018
Figure Saudi Arabia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure UAE Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure Egypt Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure Nigeria Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Figure South Africa Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2014-2019)
Table Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) by Type (2014-2019)
Table Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Type (2014-2019)
Figure Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Type (2014-2019)
Figure Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Type in 2019
Table Global Gastric Cancer Testing, Treatment and Prevention Revenue Forecast by Type (2019-2024)
Figure Global Gastric Cancer Testing, Treatment and Prevention Market Share Forecast by Type (2019-2024)
Figure Global Test Revenue Growth Rate (2014-2019)
Figure Global Treatment Revenue Growth Rate (2014-2019)
Figure Global Prevention Revenue Growth Rate (2014-2019)
Table Global Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2014-2019)
Table Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Application (2014-2019)
Figure Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Application (2014-2019)
Figure Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Application in 2019
Table Global Gastric Cancer Testing, Treatment and Prevention Revenue Forecast by Application (2019-2024)
Figure Global Gastric Cancer Testing, Treatment and Prevention Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2019-2024)
Figure Europe Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2019-2024)
Figure South America Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2019-2024)


【掲載企業】

Biogen Idec、Bristol Myers Squibb、Eli Lilly And Company、Glaxosmithkline Genentech, Inc、Hoffmann-La Roche Inc.、Immunogen Merck & Company、Novartis、Pacific Edge Diagnostics Nz、Pfizer、Roche/Genentech Oncolytics、Zova Biotherapeutics Inc.、

★調査レポート[胃がんの検査・治療・予防の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）] (コード：GIR9102024)販売に関する免責事項を必ずご確認ください。
★調査レポート[胃がんの検査・治療・予防の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 副鼻腔がん治療の世界市場：企業別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100514 / GlobalInfoResearch / 2019年9月4日 / 本調査レポートは、副鼻腔がん治療の世界市場について調べ、まとめました。種類別セグメントは、手術、放射線療法、化学療法等、用途別セグメントは、病院と診療所、がん治療研究センター、研究所、その他等に区分しました。副鼻腔がん治療の世界市場概観、企業動向、企業別副鼻腔がん治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・副鼻腔がん治療の市場概観 ・副鼻腔がん治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・副鼻腔がん治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・副鼻腔がん治療の世界市場規模 ・副鼻腔がん治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・副鼻腔がん治療のアメリカ市場規模推移 ・副鼻腔がん治療のカナダ市場規模推移 ・副鼻腔がん治療のメキシコ市場規模推移 ・副鼻腔がん治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...If cancer is in the ethmoid sinus, treatment may include the following: Surgery followed by radiation therapy. A clinical trial of combination chemotherapy before surgery or radiation therapy. A clinical trial of combination chemotherapy after surgery or other cancer treatment. Scope of the Report: The global Paranasal Sinus Cancer Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India...
  • RNAワクチンの世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101166 / GlobalInfoResearch / 2019年9月10日 / 本調査レポートは、RNAワクチンの世界市場について調べ、まとめました。種類別セグメントは、個別がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン等、用途別セグメントは、感染症、がん、その他等に区分しました。RNAワクチンの世界市場概観、メーカー動向、メーカー別RNAワクチンシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・RNAワクチンの市場概観 ・RNAワクチンの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・RNAワクチンの企業別販売動向、市場シェア、市場集中度、競争動向 ・RNAワクチンの世界市場規模 ・RNAワクチンの北米市場分析（アメリカ、カナダ、メキシコ等） ・RNAワクチンのアメリカ市場規模推移 ・RNAワクチンのカナダ市場規模推移 ・RNAワクチンのメキシコ市場規模推移 ・RNAワクチンのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies. RNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research...
  • 感染予防の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9101432 / GlobalInfoResearch / 2019年9月11日 / 本調査レポートは、感染予防の世界市場について調べ、まとめました。種類別セグメントは、消毒器、滅菌装置、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。感染予防の世界市場概観、メーカー動向、メーカー別感染予防シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・感染予防の市場概観 ・感染予防の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・感染予防の企業別販売動向、市場シェア、市場集中度、競争動向 ・感染予防の世界市場規模 ・感染予防の北米市場分析（アメリカ、カナダ、メキシコ等） ・感染予防のアメリカ市場規模推移 ・感染予防のカナダ市場規模推移 ・感染予防のメキシコ市場規模推移 ・感染予防のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Medical devices used for infection prevention. Scope of the Report: The worldwide market for Infection Prevention is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Infection Prevention in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers 3M BD Belimed Biomerieux Getinge...
  • 感染予防製品の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9103400 / GlobalInfoResearch / 2019年9月26日 / 本調査レポートは、感染予防製品の世界市場について調べ、まとめました。種類別セグメントは、設備、消耗品、その他等、用途別セグメントは、病院、診療所、その他等に区分しました。感染予防製品の世界市場概観、メーカー動向、メーカー別感染予防製品シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・感染予防製品の市場概観 ・感染予防製品の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・感染予防製品の企業別販売動向、市場シェア、市場集中度、競争動向 ・感染予防製品の世界市場規模 ・感染予防製品の北米市場分析（アメリカ、カナダ、メキシコ等） ・感染予防製品のアメリカ市場規模推移 ・感染予防製品のカナダ市場規模推移 ・感染予防製品のメキシコ市場規模推移 ・感染予防製品のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）...Products used for infection prevention. Scope of the Report: The worldwide market for Infection Prevention Products is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Infection Prevention Products in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers 3M BD Belimed Biomerieux...
  • 動物の痛み軽減および予防の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100599 / GlobalInfoResearch / 2019年9月4日 / 本調査レポートは、動物の痛み軽減および予防の世界市場について調べ、まとめました。種類別セグメントは、外部使用、内部使用等、用途別セグメントは、家畜、ペット、海洋動物等に区分しました。動物の痛み軽減および予防の世界市場概観、メーカー動向、メーカー別動物の痛み軽減および予防シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・動物の痛み軽減および予防の市場概観 ・動物の痛み軽減および予防の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・動物の痛み軽減および予防の企業別販売動向、市場シェア、市場集中度、競争動向 ・動物の痛み軽減および予防の世界市場規模 ・動物の痛み軽減および予防の北米市場分析（アメリカ、カナダ、メキシコ等） ・動物の痛み軽減および予防のアメリカ市場規模推移 ・動物の痛み軽減および予防のカナダ市場規模推移 ・動物の痛み軽減および予防のメキシコ市場規模推移 ・動物の痛み軽減および予防のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Animal Pain Relief and Prevention is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Animal Pain Relief and Prevention in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Boehringer Ingelheim Zoetis Merck...
  • 家畜の鎮痛および予防の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100605 / GlobalInfoResearch / 2019年9月5日 / 本調査レポートは、家畜の鎮痛および予防の世界市場について調べ、まとめました。種類別セグメントは、外部使用、内部使用等、用途別セグメントは、牛、馬、豚、家禽等に区分しました。家畜の鎮痛および予防の世界市場概観、メーカー動向、メーカー別家畜の鎮痛および予防シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・家畜の鎮痛および予防の市場概観 ・家畜の鎮痛および予防の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・家畜の鎮痛および予防の企業別販売動向、市場シェア、市場集中度、競争動向 ・家畜の鎮痛および予防の世界市場規模 ・家畜の鎮痛および予防の北米市場分析（アメリカ、カナダ、メキシコ等） ・家畜の鎮痛および予防のアメリカ市場規模推移 ・家畜の鎮痛および予防のカナダ市場規模推移 ・家畜の鎮痛および予防のメキシコ市場規模推移 ・家畜の鎮痛および予防のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Livestock Pain Relief and Prevention is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Livestock Pain Relief and Prevention in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Boehringer Ingelheim Zoetis Merck...
  • ペット除痛および予防の世界市場：メーカー別、地域別、種類別、用途別、市場予測（～2024）
    GIR9100611 / GlobalInfoResearch / 2019年9月5日 / 本調査レポートは、ペット除痛および予防の世界市場について調べ、まとめました。種類別セグメントは、外部使用、内部使用等、用途別セグメントは、犬、猫、その他等に区分しました。ペット除痛および予防の世界市場概観、メーカー動向、メーカー別ペット除痛および予防シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ペット除痛および予防の市場概観 ・ペット除痛および予防の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ペット除痛および予防の企業別販売動向、市場シェア、市場集中度、競争動向 ・ペット除痛および予防の世界市場規模 ・ペット除痛および予防の北米市場分析（アメリカ、カナダ、メキシコ等） ・ペット除痛および予防のアメリカ市場規模推移 ・ペット除痛および予防のカナダ市場規模推移 ・ペット除痛および予防のメキシコ市場規模推移 ・ペット除痛および予防のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）... Scope of the Report: The worldwide market for Pets Pain Relief and Prevention is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Pets Pain Relief and Prevention in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Boehringer Ingelheim Zoetis Merck...

    • ◆H&Iグローバルリサーチのお客様（例）◆